Patient Care
Education
Research
Community
Referring Physicians
Find a Physician
Departments & Centers
About URMC
Libraries
Alumni
Giving
URMC
»
Clinical Trials
»
Participate
A-
A
A+
Email this page
URMC Health Research
Participate in a Study
Open Studies
FAQ
About Clinical Research
Research at URMC
Healthy Volunteers
Links
Contact Us
ResearchMatch
Colon Cancer Clinical Trials
1.
(CGIC06001) (E5202)A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU Leucovorin, Ozaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers
2.
(CGIC05005) (C80405) Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or cetuximab (C225), or with the Combination of Bevacizumab and cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum.
3.
(CGIC04003) (N0147)A Randomized Phase III Trial of Irinotecan (CPT-11) and/or Oxaliptatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer
4.
(CGIC04003) (N0147)A Randomized Phase III Trial of Irinotecan (CPT-11) and/or Oxaliptatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer
Email this page
